|
US7258857B2
(en)
*
|
1996-11-22 |
2007-08-21 |
The Trustees Of Columbia University In The City Of New York |
Rage-related methods for treating inflammation
|
|
US6790443B2
(en)
*
|
1996-11-22 |
2004-09-14 |
The Trustees Of Columbia University In The City Of New York |
Method for treating symptoms of diabetes
|
|
US6555651B2
(en)
*
|
1997-10-09 |
2003-04-29 |
The Trustees Of Columbia University In The City Of New York |
Ligand binding site of rage and uses thereof
|
|
US7081241B1
(en)
*
|
1998-10-06 |
2006-07-25 |
The Trustees Of Columbia University In The City Of New York |
Extracellular rage binding protein (EN-RAGE) and uses thereof
|
|
US7101838B2
(en)
*
|
1997-08-05 |
2006-09-05 |
The Trustees Of Columbia University In The City Of New York |
Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts
|
|
US6465422B1
(en)
*
|
1998-04-17 |
2002-10-15 |
The Trustees Of Columbia University In The City Of New York |
Method for inhibiting tumor invasion or spreading in a subject
|
|
AU765719B2
(en)
*
|
1998-10-06 |
2003-09-25 |
Trustees Of Columbia University In The City Of New York, The |
Extracellular novel rage binding protein (EN-RAGE) and uses thereof
|
|
JP2003507013A
(ja)
*
|
1999-08-13 |
2003-02-25 |
ザ・トラスティーズ・オブ・コランビア・ユニバーシティー・イン・ザ・シティー・オブ・ニューヨーク |
βシートフィブリルのＲＡＧＥへの結合を阻害する方法及びその結果
|
|
US20050170382A1
(en)
*
|
1999-10-06 |
2005-08-04 |
The Trustees Of Columbia University In The City Of New York. |
RAGE-related compositions
|
|
US6613801B2
(en)
|
2000-05-30 |
2003-09-02 |
Transtech Pharma, Inc. |
Method for the synthesis of compounds of formula I and their uses thereof
|
|
US6908741B1
(en)
|
2000-05-30 |
2005-06-21 |
Transtech Pharma, Inc. |
Methods to identify compounds that modulate RAGE
|
|
EP1724589A3
(en)
*
|
2000-05-30 |
2007-04-25 |
TransTech Pharma Inc. |
Methods to identify compounds that modulate rage
|
|
US7919670B1
(en)
|
2000-08-14 |
2011-04-05 |
The Trustees Of Columbia University In The City Of New York |
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE) in brain and uses thereof
|
|
PE20020394A1
(es)
|
2000-08-18 |
2002-06-21 |
Agouron Pharma |
Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
|
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
|
US7723303B2
(en)
*
|
2000-08-24 |
2010-05-25 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
US7199102B2
(en)
*
|
2000-08-24 |
2007-04-03 |
The Regents Of The University Of California |
Orally administered peptides synergize statin activity
|
|
US7148197B2
(en)
*
|
2000-08-24 |
2006-12-12 |
The Regents Of The University Of California |
Orally administered small peptides synergize statin activity
|
|
AU2002213192A1
(en)
*
|
2000-10-13 |
2002-04-22 |
The Trustees Of Columbia University In The City Of New York |
A method for inhibiting new tissue growth in blood vessels in a patient subjected to blood vessel injury
|
|
CA2440037C
(en)
|
2001-03-05 |
2010-02-16 |
Transtech Pharma, Inc. |
Benzimidazole derivatives for modulating the rage receptor
|
|
EP1377295A4
(en)
|
2001-03-05 |
2007-05-09 |
Transtech Pharma Inc |
CARBOXYL ACID DERIVATIVES THERAPEUTIC AGENTS
|
|
CN101613321A
(zh)
|
2002-03-05 |
2009-12-30 |
特兰斯泰克制药公司 |
抑制配体与高级糖化终产物受体相互作用的单和双环吡咯衍生物
|
|
BR0313491A
(pt)
*
|
2002-08-16 |
2007-08-14 |
Wyeth Corp |
composições e métodos para tratar distúrbios associados ao rage
|
|
WO2004100890A2
(en)
*
|
2003-05-09 |
2004-11-25 |
The Trustees Of Columbia University In The City Of New York |
Rage g82s-related methods and compositions for treating inflammatory disorders
|
|
EP1771565B1
(en)
*
|
2004-07-20 |
2012-09-05 |
The Feinstein Institute for Medical Research |
Rage protein derivatives
|
|
MX2007001559A
(es)
*
|
2004-08-03 |
2007-04-10 |
Transtech Pharma Inc |
Proteinas de fusion de receptor para productos finales glicados avanzados y metodos de uso.
|
|
EP1776459A1
(en)
*
|
2004-08-03 |
2007-04-25 |
Transtech Pharma, Inc. |
Rage fusion proteins and methods of use
|
|
US20060205669A1
(en)
*
|
2004-09-16 |
2006-09-14 |
The Regents Of The University Of California |
G-type peptides and other agents to ameliorate atherosclerosis and other pathologies
|
|
JP2008537874A
(ja)
*
|
2004-09-27 |
2008-10-02 |
セントカー・インコーポレーテツド |
ｓＲＡＧＥミメティボディ、組成物、方法および使用
|
|
JP2008522980A
(ja)
|
2004-12-06 |
2008-07-03 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
小血管の構造および機能を改善するための方法
|
|
US9291621B2
(en)
*
|
2005-01-18 |
2016-03-22 |
AbbVie Deutschland GmbH & Co. KG |
AGER-peptides and use thereof
|
|
JP2008526243A
(ja)
*
|
2005-01-18 |
2008-07-24 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
Ａｇｅｒペプチド及びその使用
|
|
US20090220484A1
(en)
*
|
2005-03-17 |
2009-09-03 |
Ann Marie Schmidt |
Rage/Diaphanous Interaction and Related Compositions and Methods
|
|
KR20080007491A
(ko)
*
|
2005-04-29 |
2008-01-21 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
염증성 반응을 특징으로 하는 병리를 치료하기 위한 펩티드및 펩티드 모방체
|
|
US20080293639A1
(en)
*
|
2005-04-29 |
2008-11-27 |
The Regents Of The University Of California |
Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
|
|
US20080207499A1
(en)
*
|
2005-06-29 |
2008-08-28 |
Gaetano Barile |
Rage-related methods for treating and preventing diabetic retinopathy
|
|
WO2007073272A1
(en)
*
|
2005-12-23 |
2007-06-28 |
Gcoder Systems Ab |
Positioning pattern
|
|
BRPI0707640A2
(pt)
*
|
2006-02-09 |
2011-05-10 |
Transtech Pharma Inc |
proteÍnas de fusço do rage e mÉtodos de uso
|
|
NZ571692A
(en)
|
2006-05-05 |
2012-01-12 |
Transtech Pharma Inc |
Rage fusion proteins, formulations, and methods of use thereof
|
|
WO2008100470A2
(en)
*
|
2007-02-15 |
2008-08-21 |
Transtech Pharma, Inc. |
Rage - immunoglobulin fusion proteins
|
|
US20100254983A1
(en)
*
|
2007-06-07 |
2010-10-07 |
Ann Marie Schmidt |
Uses of rage antagonists for treating obesity and related diseases
|
|
CA2690056C
(en)
|
2007-06-14 |
2017-08-29 |
Galactica Pharmaceuticals, Inc. |
Rage fusion proteins
|
|
CA2704729C
(en)
|
2007-08-28 |
2020-06-23 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
CA2697957A1
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
|
KR20110139292A
(ko)
|
2009-04-20 |
2011-12-28 |
화이자 인코포레이티드 |
단백질 글리코실화의 제어 및 그와 관련된 조성물 및 방법
|
|
US8580833B2
(en)
|
2009-09-30 |
2013-11-12 |
Transtech Pharma, Inc. |
Substituted imidazole derivatives and methods of use thereof
|
|
JP5894540B2
(ja)
|
2010-02-18 |
2016-03-30 |
ブイティーブイ・セラピューティクス・エルエルシー |
フェニル−ヘテロアリール誘導体とその使用の方法
|
|
JP5999542B2
(ja)
*
|
2010-11-18 |
2016-09-28 |
国立研究開発法人農業・食品産業技術総合研究機構 |
リガンド様活性を有する分子の検出方法
|
|
US9561274B2
(en)
|
2011-06-07 |
2017-02-07 |
University Of Hawaii |
Treatment and prevention of cancer with HMGB1 antagonists
|
|
WO2012170740A2
(en)
|
2011-06-07 |
2012-12-13 |
University Of Hawaii |
Biomarker of asbestos exposure and mesothelioma
|
|
US9717710B2
(en)
|
2012-10-05 |
2017-08-01 |
Vtv Therapeutics Llc |
Treatment of mild and moderate Alzheimer's disease
|
|
KR101595630B1
(ko)
*
|
2013-01-18 |
2016-02-18 |
성균관대학교산학협력단 |
Rage 단백질-베타아밀로이드 상호작용 억제제, 및 이를 유효성분으로 함유하는 베타아밀로이드 집적 관련 질환의 예방 또는 치료용 약학적 조성물
|
|
US10653747B2
(en)
|
2014-07-31 |
2020-05-19 |
Uab Research Foundation |
ApoE mimetic peptides and higher potency to clear plasma cholesterol
|
|
WO2019190822A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Crystalline forms of [3-(4- {2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
WO2019190823A1
(en)
|
2018-03-28 |
2019-10-03 |
Vtv Therapeutics Llc |
Pharmaceutically acceptable salts of [3-(4- {2-butyl-1-[4-(4-chlorophenoxy)-phenyl]-1h-imidazol-4-yl} -phenoxy)-propyl]-diethyl-amine
|
|
EP3864008A1
(en)
|
2018-10-10 |
2021-08-18 |
vTv Therapeutics LLC |
Metabolites of [3-(4-{2-butyl-l-[4-(4-chloro-phenoxy)-phenyl]-lh-imidazol-4-yl } -phen ox y)-prop yl] -diethyl-amine
|